Cargando…
Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574732/ https://www.ncbi.nlm.nih.gov/pubmed/36048879 http://dx.doi.org/10.1002/psp4.12860 |
_version_ | 1784811166366695424 |
---|---|
author | Yamazaki, Shinji Evers, Raymond De Zwart, Loeckie |
author_facet | Yamazaki, Shinji Evers, Raymond De Zwart, Loeckie |
author_sort | Yamazaki, Shinji |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9574732 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95747322022-10-17 Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition Yamazaki, Shinji Evers, Raymond De Zwart, Loeckie CPT Pharmacometrics Syst Pharmacol Corrigendum John Wiley and Sons Inc. 2022-09-01 2022-10 /pmc/articles/PMC9574732/ /pubmed/36048879 http://dx.doi.org/10.1002/psp4.12860 Text en © 2022 The Authors. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals LLC on behalf of the American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Corrigendum Yamazaki, Shinji Evers, Raymond De Zwart, Loeckie Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition |
title | Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition |
title_full | Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition |
title_fullStr | Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition |
title_full_unstemmed | Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition |
title_short | Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition |
title_sort | corrigendum to: physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal p‐glycoprotein inhibition |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574732/ https://www.ncbi.nlm.nih.gov/pubmed/36048879 http://dx.doi.org/10.1002/psp4.12860 |
work_keys_str_mv | AT yamazakishinji corrigendumtophysiologicallybasedpharmacokineticmodelingtoevaluateinvitrotoinvivoextrapolationforintestinalpglycoproteininhibition AT eversraymond corrigendumtophysiologicallybasedpharmacokineticmodelingtoevaluateinvitrotoinvivoextrapolationforintestinalpglycoproteininhibition AT dezwartloeckie corrigendumtophysiologicallybasedpharmacokineticmodelingtoevaluateinvitrotoinvivoextrapolationforintestinalpglycoproteininhibition |